<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did UBX's operating expenses trend in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 11:42pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Unity Biotechnology, Inc. (UBX) did not report any operating expenses in Q4 2024.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af){return {layout:"default",data:[{noData:c,currentQuestion:d,textDescription:G,comeFrom:"AInvestShareLink",events:[],answerSource:i}],fetch:{},error:j,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:k,agent_id:a,output_media_info:[],task_id:a,language:a,source:i,cache_builder:a,reply_action:"Answer",execute_mode:v,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did UBX's operating expenses trend in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did UBX's operating expenses trend in Q4 2024?\",\"user_id\":\"dp02180154\",\"user_name\":\"\",\"trace_id\":\"faacb661-4b66-4d18-962f-3b0248601a70\",\"session_id\":\"faacb661-4b66-4d18-962f-3b0248601a70\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:w,text:"0 results found:\n",query_data:{number:k,title:x,query_type:w,condition:a,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e}}}],answer_chain_name:I,agent_mode:J,native_answer:a,come_from:a,text_answer:G,trace_id:f,cost:10503,event_names:a,question:d,fallback_type:K,input_type:L,fall_back_reason:{fall_back_type:K,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:f,first_return_cost:2071,cache_type:"no_cache",question_id:f,transfer_question:d,signal_type:"ON_COMPLETE",start_time:y,remote_svc:i,slots:[],answer_type:v,user_id:s,skill_name:z},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:f,session_id:f,user_id:s,question:d,source:i,raw_question:d,version:"3.4.1",action_name:z,nlu:{entity:[{type:M,value:"UBX.O",market:N}]},output_time:y,deep_research:c,deep_thinking:c,agent_mode:J},extra:{}},{answer_path:l,section:{id:m,info_texts:["Thinking"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:l,section:{id:m,info_texts:["Querying Stock: UBX Operating Expenses in Q4 2024"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:O},logs:[],extra:{action:"Querying Stock",action_input:x,thought:"The user seeks to analyze UBX's Q4 2024 operating expenses. I should focus on its Q4 2024 operating expenses data. I will use FinQuery for the data mentioned above."}},{answer_path:g,section:{id:A,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Searching Web: Unity Biotechnology Operating Expenses in Q4 2024"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:O},logs:[],extra:{action:"Searching Web",action_input:"Unity Biotechnology Operating Expenses in Q4 2024",thought:"I am unable to obtain UBX's Q4 2024 operating expenses using FinQuery, now I will try again using Search."}},{answer_path:g,section:{id:A,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:A,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Generating Answer"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:g,section:{id:B,info_texts:[],show_type:C,voice_txt:"Unity",text_answer:P,rich_text:P,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:2000,info_texts:[],show_type:C,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:x,query_type:w,trace_data:a,index:k,model_sql:H,data_ext_params:{merge_repeat:c,expand_index:b,data_add:k,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:g,section:{id:B,info_texts:[],show_type:C,voice_txt:D,text_answer:D,rich_text:D,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:g,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"UBX",market_id:N,name:Q,domain:M},pos:e,section_id:B,txt:Q,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Completed"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:o,query_text:o,trace_info:{item_id:"2c929faf21fec5dc996380248adcb415",item_type:h,item_name:o,rec_info:R}},{display_text:p,query_text:p,trace_info:{item_id:"8a17be3469ed9fc708fda8a0d23fecf5",item_type:h,item_name:p,rec_info:S}},{display_text:q,query_text:q,trace_info:{item_id:"94f78002184c2169cc0ff6a7bb26be3b",item_type:h,item_name:q,rec_info:T}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:U,related_name:V}],puuid:E,tag:a,category:"custom",uuid:W}],global:{urp_static_data:[{name:V,value:{status_code:e,columns:[{type:r,index_name:X,key:X},{type:r,index_name:Y,key:Y},{type:r,index_name:Z,key:Z},{type:r,index_name:_,key:_},{type:r,index_name:$,key:$}],datas:[{send_text:o,item_type:h,rec_info:R,display_text:o,rec_reason:a},{send_text:p,item_type:h,rec_info:S,display_text:p,rec_reason:a},{send_text:q,item_type:h,rec_info:T,display_text:q,rec_reason:a}],dataSize:U,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:aa,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:u,"min-height":"100%",position:ab,height:u},isMaterial:c,id:aa,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:F,componentUuid:W,script:[{name:ac,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:F,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:F},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:u,position:ab,height:u},isMaterial:b,_id:19,id:ac,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ad,voice_txt:a,tracking_info:{},uuid:E},order:{is_auto:c,render_for:ad,chart_type:"command",puuid:E}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:z,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:v,answer_chain_name:I},is_deep_research:c,deep_thinking:c,create_time:1746718983669},is_last:b}],questionItem:{data:{qStr:d,encodeFlag:c,imageData:j,docsData:[],quoteData:j},tplType:"question"},events:ae,agentId:a,param:{entity_info:{},add_info:{ori_question:d},event_list:ae,client_ip:a,question:d,user_id:s,user_name:a,trace_id:f,session_id:f,source:i,input_type:L}}],userId:s,userName:a,startTime:y,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:j,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:j,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-ubxs-operating-expenses-trend-in-q4-2024-1750fc\u002F",config:{_app:{basePath:af,assetsPath:af,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"How did UBX's operating expenses trend in Q4 2024?",0,"faacb661-4b66-4d18-962f-3b0248601a70","other\u002FopenAnswer","llm_generated","ths_ainvest_lite_web",null,1,"progress\u002Fsearching_for",1000,"searching_for","Did UBX's operating expenses in Q4 2024 exceed analyst expectations?","How did UBX's operating expenses in Q4 2024 impact its profit margins?","What were UBX's operating expenses in Q4 2024 compared to the previous quarter?","STR","dp02180154","signal","auto","agent","intusstock","UBX Operating Expenses in Q4 2024",1746718973166,"review stocks",999,2001,"rich_text",".","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Unity Biotechnology, Inc. (UBX) did not report any operating expenses in Q4 2024.","select   stock_code,   operating_expenses from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'UBX.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","185","thinking","Unity Biotechnology, Inc. (UBX) did not report any operating expenses in Q4 2024[^1]","Unity Biotechnology","2+679_496_21_554+0+0+faacb661-4b66-4d18-962f-3b0248601a70+2c929faf21fec5dc996380248adcb415+llm_generated+aimeTagAnalysis+0+0.007163158152252436+1","2+679_496_21_554+0+0+faacb661-4b66-4d18-962f-3b0248601a70+8a17be3469ed9fc708fda8a0d23fecf5+llm_generated+aimeTagAnalysis+0+0.00546626141294837+2","2+679_496_21_554+0+0+faacb661-4b66-4d18-962f-3b0248601a70+94f78002184c2169cc0ff6a7bb26be3b+llm_generated+aimeTagAnalysis+0+0.0035465790424495935+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>